MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies

Ryan A Langlois1,2, Randy A Albrecht1,2, Brian Kimble3

  • 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.

Nature Biotechnology
|August 13, 2013
PubMed

Insights

Researchers developed a molecular biocontainment strategy using microRNA-192 to enhance biosafety in gain-of-function influenza A virus (H5N1) research. This method limits viral spread in specific hosts, reducing risks associated with dangerous virus studies.

Area of Science:

  • Virology
  • Molecular Biology
  • Biotechnology

Background:

  • Gain-of-function studies on influenza A virus (H5N1) have raised biosafety concerns due to potential human transmissibility.
  • Influenza A virus H5N1 hemagglutinin mutations can confer ferret transmissibility, a surrogate for human transmission.

Purpose of the Study:

  • To develop and assess a molecular biocontainment strategy to enhance biosafety in gain-of-function influenza virus research.
  • To investigate the use of species-specific endogenous small RNAs to restrict influenza virus tropism.

Main Methods:

  • Exploited species-specific microRNA (miRNA) targeting to restrict influenza virus tropism.
  • Identified miR-192 as present in human and mouse respiratory cells but absent in ferrets.
  • Engineered influenza A virus with miR-192 target sites.

Main Results:

  • Engineered influenza A virus replicated and transmitted in ferrets without significant attenuation.
  • Influenza virus with miR-192 target sites showed attenuated pathogenicity in mice.
  • Demonstrated the potential of molecular biocontainment using endogenous small RNAs.

Conclusions:

  • Molecular biocontainment using species-specific miRNAs offers a promising approach to enhance biosafety in gain-of-function influenza research.
  • This strategy can be applied to minimize risks associated with experiments involving other pathogenic viruses.